Prism Pharmaceuticals

Prism Pharmaceuticals

Acute care pharmaceutical company engaged in developing and commercializing cardiovascular injectable products
King of Prussia United States (HQ)

Company information

Edit
Launch date
Employees
9 people
Firm valuation
€55—82m (Dealroom.co estimates Jun 2013.)
  • Edit
DateInvestorsAmountRound
N/AN/ASERIES A
$15mSERIES B
$338m
Valuation: $338m
ACQUISITION
N/A$15mSERIES C
Total Funding€27.3m

Recent News about Prism Pharmaceuticals

Edit
LocationEdit
United States, King of Prussia
Are you an employee or an investor of this company?
Add your profile